Common use of Upfront Payment Clause in Contracts

Upfront Payment. The Opt-In Party will pay to Regulus, within 15 days following the end of the Second Opt-In Election Period, a one-time payment of [***] Dollars ($[***]).

Appears in 3 contracts

Sources: License and Collaboration Agreement (Isis Pharmaceuticals Inc), License and Collaboration Agreement (Isis Pharmaceuticals Inc), License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)

Upfront Payment. The Opt-In Party will pay to Regulus, within 15 days following the end of the Second Initial Opt-In Election Period, a one-time payment of [***] Dollars ($[***]).

Appears in 3 contracts

Sources: License and Collaboration Agreement (Isis Pharmaceuticals Inc), License and Collaboration Agreement (Isis Pharmaceuticals Inc), License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)

Upfront Payment. The Opt-In Party will pay to Regulus, within 15 days following the end of the Second Opt-In Election Period, a one-time payment of [...***...] Dollars ($[...***...]).

Appears in 2 contracts

Sources: License and Collaboration Agreement (Regulus Therapeutics Inc.), License and Collaboration Agreement (Regulus Therapeutics Inc.)

Upfront Payment. The Opt-In Party will pay to Regulus, within 15 days following the end of the Second Initial Opt-In Election Period, a one-time payment of [...***...] Dollars ($[...***...]).

Appears in 2 contracts

Sources: License and Collaboration Agreement (Regulus Therapeutics Inc.), License and Collaboration Agreement (Regulus Therapeutics Inc.)

Upfront Payment. The Opt-In Party will pay to Regulus, within 15 days following the end of the Second Opt-In Election Period, a one-time payment of [***] Dollars ($[***]).

Appears in 1 contract

Sources: License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)

Upfront Payment. The Opt-In Party will pay to Regulus, within 15 days following the end of the Second Initial Opt-In Election Period, a one-time payment of [***] Dollars ($[***]).

Appears in 1 contract

Sources: License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)